About Cylex: Investors

Cylex is a venture-backed, privately held global life sciences company whose investors are leaders in life science investing. In addition to the expertise of the Cylex Board of Directors, each investor brings considerable strategic, financial and scientific expertise to the Company.

Canaan Partners is a global venture capital firm that invests in people who turn visionary ideas into valuable and significant technology and healthcare companies. They were early investors in some of the world’s leading technology companies, including Acme Packet, CommerceOne, DoubleClick and Match.com and as well as healthcare giants Cerexa, Dexcom, Northstar Neuroscience and Peninsula Pharmaceuticals.

http://www.canaan.com

Channel Medical Partners invests solely in public emerging growth companies in the medical technology industries. In this market segment, the Fund not only acts as a significant source of capital, it also adds substantial value by helping portfolio compnies put into place the capabilities required for success. Over the past few years, they have led some of the larger transactions completed in the medical technology industry.

http://www.chanmed.com

First Analysis is a leading private growth equity investor. They have one of the longest records (23 years) in private capital investing, transitioning through three major long-term investment cycles. They have invested over $650 million across multiple highly diversified funds and created over $1.5 billion in fund liquidations. The Company has over $260 million in active portfolio investments.  They apply a unique strategy - achieving broad, deep, and long-term domain expertise through a research and investment focus that encompasses both private and public companies. This approach yields valuable perspective and service.

http://www.firstanalysis.com

Roche Venture Fund which invests in early stage biotech and diagnostics companies to support innovative technologies and medicines. Based in Basel, Switzerland, the Roche Venture Fund, with a portfolio of over 25 companies in 10 countries, is constantly seeking new investment opportunities in innovative companies with novel technologies.

http://www.venturefund.roche.com

http://www.siemens.com/venturecapital